Daré Bioscience, Inc.
DARE
$2.82
-$0.10-3.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.40K | -63.60K | 41.70K | 22.40K | 9.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.40K | -63.60K | 41.70K | 22.40K | 9.30K |
| Cost of Revenue | 2.30M | 14.22M | 25.00K | 25.00K | 3.36M |
| Gross Profit | -2.27M | -14.29M | 16.70K | -2.60K | -3.35M |
| SG&A Expenses | 2.31M | 2.00M | 2.04M | 2.45M | 2.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.61M | 5.32M | 4.72M | 7.38M | 6.03M |
| Operating Income | -4.58M | -5.39M | -4.68M | -7.36M | -6.02M |
| Income Before Tax | -4.38M | -5.51M | -4.70M | 12.91M | -6.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.38M | -5.51M | -4.70M | 12.91M | -6.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.38M | -5.51M | -4.70M | 12.91M | -6.76M |
| EBIT | -4.58M | -5.39M | -4.68M | -7.36M | -6.02M |
| EBITDA | -4.42M | -5.38M | -4.67M | -7.34M | -6.01M |
| EPS Basic | -0.50 | -0.69 | -0.55 | 1.53 | -0.81 |
| Normalized Basic EPS | -0.31 | -0.48 | -0.34 | 0.96 | -0.50 |
| EPS Diluted | -0.50 | -0.69 | -0.55 | 1.52 | -0.81 |
| Normalized Diluted EPS | -0.31 | -0.48 | -0.34 | 0.95 | -0.50 |
| Average Basic Shares Outstanding | 8.76M | 8.02M | 8.53M | 8.41M | 8.38M |
| Average Diluted Shares Outstanding | 8.76M | 8.02M | 8.53M | 8.48M | 8.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |